Alphabet, Hims & Hers Health, Tempus AI, UnitedHealth Group, and Axon Enterprise are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are equity shares of companies operating in the healthcare sector—this includes pharmaceutical manufacturers, biotechnology firms, medical device makers and healthcare service providers. By investing in these stocks, shareholders gain exposure to the sector’s growth driven by medical innovation and demographic trends, while also taking on risks from regulatory shifts, patent expirations and clinical‐trial outcomes. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
Alphabet (GOOGL)
Alphabet Inc. offers various products and platforms in the United States, Europe, the Middle East, Africa, the Asia-Pacific, Canada, and Latin America. It operates through Google Services, Google Cloud, and Other Bets segments. The Google Services segment provides products and services, including ads, Android, Chrome, devices, Gmail, Google Drive, Google Maps, Google Photos, Google Play, Search, and YouTube.
Shares of NASDAQ:GOOGL traded up $3.39 during trading on Thursday, hitting $154.77. 35,078,131 shares of the company were exchanged, compared to its average volume of 28,591,950. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.03. The firm has a fifty day moving average price of $159.54 and a two-hundred day moving average price of $175.25. Alphabet has a fifty-two week low of $140.53 and a fifty-two week high of $207.05. The stock has a market cap of $1.88 trillion, a price-to-earnings ratio of 19.23, a P/E/G ratio of 1.34 and a beta of 1.01.
Read Our Latest Research Report on GOOGL
Hims & Hers Health (HIMS)
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
NYSE:HIMS traded down $0.20 on Thursday, hitting $52.15. The company's stock had a trading volume of 49,612,212 shares, compared to its average volume of 17,959,781. The stock has a fifty day moving average of $32.52 and a two-hundred day moving average of $31.96. The firm has a market capitalization of $11.59 billion, a P/E ratio of 118.53 and a beta of 1.84. Hims & Hers Health has a one year low of $11.64 and a one year high of $72.98.
Read Our Latest Research Report on HIMS
Tempus AI (TEM)
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Tempus AI stock traded up $6.46 during trading hours on Thursday, hitting $65.22. The company had a trading volume of 17,911,712 shares, compared to its average volume of 12,709,850. The firm has a 50-day moving average of $47.93 and a 200 day moving average of $50.76. Tempus AI has a one year low of $22.89 and a one year high of $91.45. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.
Read Our Latest Research Report on TEM
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
UnitedHealth Group stock traded down $2.03 during midday trading on Thursday, hitting $389.03. The company's stock had a trading volume of 2,955,978 shares, compared to its average volume of 4,661,467. The company has a 50-day moving average price of $491.52 and a two-hundred day moving average price of $525.18. The company has a market cap of $354.11 billion, a price-to-earnings ratio of 25.10, a PEG ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group has a 1-year low of $385.70 and a 1-year high of $630.73.
Read Our Latest Research Report on UNH
Axon Enterprise (AXON)
Axon Enterprise, Inc. develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
NASDAQ:AXON traded up $90.74 during mid-day trading on Thursday, reaching $692.56. The stock had a trading volume of 1,048,003 shares, compared to its average volume of 758,211. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise has a 12 month low of $273.52 and a 12 month high of $715.99. The stock has a market capitalization of $53.91 billion, a PE ratio of 178.96, a P/E/G ratio of 5.17 and a beta of 1.24. The stock has a 50-day simple moving average of $558.13 and a two-hundred day simple moving average of $580.55.
Read Our Latest Research Report on AXON
Featured Stories
Before you consider Alphabet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alphabet wasn't on the list.
While Alphabet currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report